Global Paclitaxel Injection Market Insights and Forecast to 2028

Q: Who are the key players in the paclitaxel injection market?

Some of the key players are Bristol–Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare, Beijing Union, Haiyao, Chuntch, Russia, Others.

Code: QYRE-Auto-18136

Report

January 2022

Pages:113

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Khandelwal Laboratories

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

Market Analysis and Insights: Global Paclitaxel Injection Market

Due to the COVID-19 pandemic, the global Paclitaxel Injection market size is estimated to be worth US$ 3791.6 million in 2022 and is forecast to a readjusted size of US$ 7130.2 million by 2028 with a CAGR of 11.1% during the review period.

Fully considering the economic change by this health crisis, 5ml,30mg accounting for % of the Paclitaxel Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Ovarian Cancer segment is altered to an % CAGR throughout this forecast period.

Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.

Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.

In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.

Global Paclitaxel Injection Scope and Segment

Paclitaxel Injection market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Paclitaxel Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

5ml,30mg

10ml,60mg

16.7ml,100mg

25ml,150mg

50ml,300mg

Segment by Application

Ovarian Cancer

Breast Cancer

Cervical Cancer

Pancreatic Cancer

Other

BY COMPANY

Bristol-Myers Squibb

Celgene Corporation

Hospira

Biological E.

Taj Accura

Khandelwal Laboratories

Luye Pharma

Beijing Youcare

Beijing Union

Haiyao

Chuntch

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

FEATURED COMPANIES

Khandelwal Laboratories

1 Study Coverage

1.1 Paclitaxel Injection Product Introduction

1.2 Market by Type

1.2.1 Global Paclitaxel Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 5ml,30mg

1.2.3 10ml,60mg

1.2.4 16.7ml,100mg

1.2.5 25ml,150mg

1.2.6 50ml,300mg

1.3 Market by Application

1.3.1 Global Paclitaxel Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Ovarian Cancer

1.3.3 Breast Cancer

1.3.4 Cervical Cancer

1.3.5 Pancreatic Cancer

1.3.6 Other

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Paclitaxel Injection Sales Estimates and Forecasts 2017-2028

2.2 Global Paclitaxel Injection Revenue Estimates and Forecasts 2017-2028

2.3 Global Paclitaxel Injection Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Paclitaxel Injection Sales by Region

2.4.1 Global Paclitaxel Injection Sales by Region (2017-2022)

2.4.2 Global Sales Paclitaxel Injection by Region (2023-2028)

2.5 Global Paclitaxel Injection Revenue by Region

2.5.1 Global Paclitaxel Injection Revenue by Region (2017-2022)

2.5.2 Global Paclitaxel Injection Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Paclitaxel Injection Sales by Manufacturers

3.1.1 Global Top Paclitaxel Injection Manufacturers by Sales (2017-2022)

3.1.2 Global Paclitaxel Injection Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Paclitaxel Injection in 2021

3.2 Global Paclitaxel Injection Revenue by Manufacturers

3.2.1 Global Paclitaxel Injection Revenue by Manufacturers (2017-2022)

3.2.2 Global Paclitaxel Injection Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel Injection Revenue in 2021

3.3 Global Paclitaxel Injection Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Paclitaxel Injection Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Paclitaxel Injection Sales by Type

4.1.1 Global Paclitaxel Injection Historical Sales by Type (2017-2022)

4.1.2 Global Paclitaxel Injection Forecasted Sales by Type (2023-2028)

4.1.3 Global Paclitaxel Injection Sales Market Share by Type (2017-2028)

4.2 Global Paclitaxel Injection Revenue by Type

4.2.1 Global Paclitaxel Injection Historical Revenue by Type (2017-2022)

4.2.2 Global Paclitaxel Injection Forecasted Revenue by Type (2023-2028)

4.2.3 Global Paclitaxel Injection Revenue Market Share by Type (2017-2028)

4.3 Global Paclitaxel Injection Price by Type

4.3.1 Global Paclitaxel Injection Price by Type (2017-2022)

4.3.2 Global Paclitaxel Injection Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Paclitaxel Injection Sales by Application

5.1.1 Global Paclitaxel Injection Historical Sales by Application (2017-2022)

5.1.2 Global Paclitaxel Injection Forecasted Sales by Application (2023-2028)

5.1.3 Global Paclitaxel Injection Sales Market Share by Application (2017-2028)

5.2 Global Paclitaxel Injection Revenue by Application

5.2.1 Global Paclitaxel Injection Historical Revenue by Application (2017-2022)

5.2.2 Global Paclitaxel Injection Forecasted Revenue by Application (2023-2028)

5.2.3 Global Paclitaxel Injection Revenue Market Share by Application (2017-2028)

5.3 Global Paclitaxel Injection Price by Application

5.3.1 Global Paclitaxel Injection Price by Application (2017-2022)

5.3.2 Global Paclitaxel Injection Price Forecast by Application (2023-2028)

6 North America

6.1 North America Paclitaxel Injection Market Size by Type

6.1.1 North America Paclitaxel Injection Sales by Type (2017-2028)

6.1.2 North America Paclitaxel Injection Revenue by Type (2017-2028)

6.2 North America Paclitaxel Injection Market Size by Application

6.2.1 North America Paclitaxel Injection Sales by Application (2017-2028)

6.2.2 North America Paclitaxel Injection Revenue by Application (2017-2028)

6.3 North America Paclitaxel Injection Market Size by Country

6.3.1 North America Paclitaxel Injection Sales by Country (2017-2028)

6.3.2 North America Paclitaxel Injection Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Paclitaxel Injection Market Size by Type

7.1.1 Europe Paclitaxel Injection Sales by Type (2017-2028)

7.1.2 Europe Paclitaxel Injection Revenue by Type (2017-2028)

7.2 Europe Paclitaxel Injection Market Size by Application

7.2.1 Europe Paclitaxel Injection Sales by Application (2017-2028)

7.2.2 Europe Paclitaxel Injection Revenue by Application (2017-2028)

7.3 Europe Paclitaxel Injection Market Size by Country

7.3.1 Europe Paclitaxel Injection Sales by Country (2017-2028)

7.3.2 Europe Paclitaxel Injection Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Paclitaxel Injection Market Size by Type

8.1.1 Asia Pacific Paclitaxel Injection Sales by Type (2017-2028)

8.1.2 Asia Pacific Paclitaxel Injection Revenue by Type (2017-2028)

8.2 Asia Pacific Paclitaxel Injection Market Size by Application

8.2.1 Asia Pacific Paclitaxel Injection Sales by Application (2017-2028)

8.2.2 Asia Pacific Paclitaxel Injection Revenue by Application (2017-2028)

8.3 Asia Pacific Paclitaxel Injection Market Size by Region

8.3.1 Asia Pacific Paclitaxel Injection Sales by Region (2017-2028)

8.3.2 Asia Pacific Paclitaxel Injection Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Paclitaxel Injection Market Size by Type

9.1.1 Latin America Paclitaxel Injection Sales by Type (2017-2028)

9.1.2 Latin America Paclitaxel Injection Revenue by Type (2017-2028)

9.2 Latin America Paclitaxel Injection Market Size by Application

9.2.1 Latin America Paclitaxel Injection Sales by Application (2017-2028)

9.2.2 Latin America Paclitaxel Injection Revenue by Application (2017-2028)

9.3 Latin America Paclitaxel Injection Market Size by Country

9.3.1 Latin America Paclitaxel Injection Sales by Country (2017-2028)

9.3.2 Latin America Paclitaxel Injection Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Paclitaxel Injection Market Size by Type

10.1.1 Middle East and Africa Paclitaxel Injection Sales by Type (2017-2028)

10.1.2 Middle East and Africa Paclitaxel Injection Revenue by Type (2017-2028)

10.2 Middle East and Africa Paclitaxel Injection Market Size by Application

10.2.1 Middle East and Africa Paclitaxel Injection Sales by Application (2017-2028)

10.2.2 Middle East and Africa Paclitaxel Injection Revenue by Application (2017-2028)

10.3 Middle East and Africa Paclitaxel Injection Market Size by Country

10.3.1 Middle East and Africa Paclitaxel Injection Sales by Country (2017-2028)

10.3.2 Middle East and Africa Paclitaxel Injection Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Corporation Information

11.1.2 Bristol-Myers Squibb Overview

11.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Bristol-Myers Squibb Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Bristol-Myers Squibb Recent Developments

11.2 Celgene Corporation

11.2.1 Celgene Corporation Corporation Information

11.2.2 Celgene Corporation Overview

11.2.3 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Celgene Corporation Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Celgene Corporation Recent Developments

11.3 Hospira

11.3.1 Hospira Corporation Information

11.3.2 Hospira Overview

11.3.3 Hospira Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Hospira Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Hospira Recent Developments

11.4 Biological E.

11.4.1 Biological E. Corporation Information

11.4.2 Biological E. Overview

11.4.3 Biological E. Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Biological E. Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Biological E. Recent Developments

11.5 Taj Accura

11.5.1 Taj Accura Corporation Information

11.5.2 Taj Accura Overview

11.5.3 Taj Accura Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Taj Accura Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Taj Accura Recent Developments

11.6 Khandelwal Laboratories

11.6.1 Khandelwal Laboratories Corporation Information

11.6.2 Khandelwal Laboratories Overview

11.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Khandelwal Laboratories Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Khandelwal Laboratories Recent Developments

11.7 Luye Pharma

11.7.1 Luye Pharma Corporation Information

11.7.2 Luye Pharma Overview

11.7.3 Luye Pharma Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Luye Pharma Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Luye Pharma Recent Developments

11.8 Beijing Youcare

11.8.1 Beijing Youcare Corporation Information

11.8.2 Beijing Youcare Overview

11.8.3 Beijing Youcare Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Beijing Youcare Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Beijing Youcare Recent Developments

11.9 Beijing Union

11.9.1 Beijing Union Corporation Information

11.9.2 Beijing Union Overview

11.9.3 Beijing Union Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Beijing Union Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Beijing Union Recent Developments

11.10 Haiyao

11.10.1 Haiyao Corporation Information

11.10.2 Haiyao Overview

11.10.3 Haiyao Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Haiyao Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Haiyao Recent Developments

11.11 Chuntch

11.11.1 Chuntch Corporation Information

11.11.2 Chuntch Overview

11.11.3 Chuntch Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 Chuntch Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Chuntch Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Paclitaxel Injection Industry Chain Analysis

12.2 Paclitaxel Injection Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Paclitaxel Injection Production Mode & Process

12.4 Paclitaxel Injection Sales and Marketing

12.4.1 Paclitaxel Injection Sales Channels

12.4.2 Paclitaxel Injection Distributors

12.5 Paclitaxel Injection Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Paclitaxel Injection Industry Trends

13.2 Paclitaxel Injection Market Drivers

13.3 Paclitaxel Injection Market Challenges

13.4 Paclitaxel Injection Market Restraints

14 Key Findings in The Global Paclitaxel Injection Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Khandelwal Laboratories

List of Tables

Table 1. Global Paclitaxel Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of 5ml,30mg

Table 3. Major Manufacturers of 10ml,60mg

Table 4. Major Manufacturers of 16.7ml,100mg

Table 5. Major Manufacturers of 25ml,150mg

Table 6. Major Manufacturers of 50ml,300mg

Table 7. Global Paclitaxel Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 8. Global Paclitaxel Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 9. Global Paclitaxel Injection Sales by Region (2017-2022) & (K Units)

Table 10. Global Paclitaxel Injection Sales Market Share by Region (2017-2022)

Table 11. Global Paclitaxel Injection Sales by Region (2023-2028) & (K Units)

Table 12. Global Paclitaxel Injection Sales Market Share by Region (2023-2028)

Table 13. Global Paclitaxel Injection Revenue by Region (2017-2022) & (US$ Million)

Table 14. Global Paclitaxel Injection Revenue Market Share by Region (2017-2022)

Table 15. Global Paclitaxel Injection Revenue by Region (2023-2028) & (US$ Million)

Table 16. Global Paclitaxel Injection Revenue Market Share by Region (2023-2028)

Table 17. Global Paclitaxel Injection Sales by Manufacturers (2017-2022) & (K Units)

Table 18. Global Paclitaxel Injection Sales Share by Manufacturers (2017-2022)

Table 19. Global Paclitaxel Injection Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 20. Global Paclitaxel Injection Revenue Share by Manufacturers (2017-2022)

Table 21. Paclitaxel Injection Price by Manufacturers (2017-2022) &(USD/Unit)

Table 22. Global Paclitaxel Injection Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Paclitaxel Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel Injection as of 2021)

Table 24. Paclitaxel Injection Manufacturing Base Distribution and Headquarters

Table 25. Manufacturers Paclitaxel Injection Product Offered

Table 26. Date of Manufacturers Enter into Paclitaxel Injection Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Paclitaxel Injection Sales by Type (2017-2022) & (K Units)

Table 29. Global Paclitaxel Injection Sales by Type (2023-2028) & (K Units)

Table 30. Global Paclitaxel Injection Sales Share by Type (2017-2022)

Table 31. Global Paclitaxel Injection Sales Share by Type (2023-2028)

Table 32. Global Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)

Table 33. Global Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)

Table 34. Global Paclitaxel Injection Revenue Share by Type (2017-2022)

Table 35. Global Paclitaxel Injection Revenue Share by Type (2023-2028)

Table 36. Paclitaxel Injection Price by Type (2017-2022) & (USD/Unit)

Table 37. Global Paclitaxel Injection Price Forecast by Type (2023-2028) & (USD/Unit)

Table 38. Global Paclitaxel Injection Sales by Application (2017-2022) & (K Units)

Table 39. Global Paclitaxel Injection Sales by Application (2023-2028) & (K Units)

Table 40. Global Paclitaxel Injection Sales Share by Application (2017-2022)

Table 41. Global Paclitaxel Injection Sales Share by Application (2023-2028)

Table 42. Global Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)

Table 43. Global Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)

Table 44. Global Paclitaxel Injection Revenue Share by Application (2017-2022)

Table 45. Global Paclitaxel Injection Revenue Share by Application (2023-2028)

Table 46. Paclitaxel Injection Price by Application (2017-2022) & (USD/Unit)

Table 47. Global Paclitaxel Injection Price Forecast by Application (2023-2028) & (USD/Unit)

Table 48. North America Paclitaxel Injection Sales by Type (2017-2022) & (K Units)

Table 49. North America Paclitaxel Injection Sales by Type (2023-2028) & (K Units)

Table 50. North America Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)

Table 51. North America Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)

Table 52. North America Paclitaxel Injection Sales by Application (2017-2022) & (K Units)

Table 53. North America Paclitaxel Injection Sales by Application (2023-2028) & (K Units)

Table 54. North America Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)

Table 55. North America Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)

Table 56. North America Paclitaxel Injection Sales by Country (2017-2022) & (K Units)

Table 57. North America Paclitaxel Injection Sales by Country (2023-2028) & (K Units)

Table 58. North America Paclitaxel Injection Revenue by Country (2017-2022) & (US$ Million)

Table 59. North America Paclitaxel Injection Revenue by Country (2023-2028) & (US$ Million)

Table 60. Europe Paclitaxel Injection Sales by Type (2017-2022) & (K Units)

Table 61. Europe Paclitaxel Injection Sales by Type (2023-2028) & (K Units)

Table 62. Europe Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)

Table 63. Europe Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)

Table 64. Europe Paclitaxel Injection Sales by Application (2017-2022) & (K Units)

Table 65. Europe Paclitaxel Injection Sales by Application (2023-2028) & (K Units)

Table 66. Europe Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)

Table 67. Europe Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)

Table 68. Europe Paclitaxel Injection Sales by Country (2017-2022) & (K Units)

Table 69. Europe Paclitaxel Injection Sales by Country (2023-2028) & (K Units)

Table 70. Europe Paclitaxel Injection Revenue by Country (2017-2022) & (US$ Million)

Table 71. Europe Paclitaxel Injection Revenue by Country (2023-2028) & (US$ Million)

Table 72. Asia Pacific Paclitaxel Injection Sales by Type (2017-2022) & (K Units)

Table 73. Asia Pacific Paclitaxel Injection Sales by Type (2023-2028) & (K Units)

Table 74. Asia Pacific Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)

Table 75. Asia Pacific Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)

Table 76. Asia Pacific Paclitaxel Injection Sales by Application (2017-2022) & (K Units)

Table 77. Asia Pacific Paclitaxel Injection Sales by Application (2023-2028) & (K Units)

Table 78. Asia Pacific Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)

Table 79. Asia Pacific Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)

Table 80. Asia Pacific Paclitaxel Injection Sales by Region (2017-2022) & (K Units)

Table 81. Asia Pacific Paclitaxel Injection Sales by Region (2023-2028) & (K Units)

Table 82. Asia Pacific Paclitaxel Injection Revenue by Region (2017-2022) & (US$ Million)

Table 83. Asia Pacific Paclitaxel Injection Revenue by Region (2023-2028) & (US$ Million)

Table 84. Latin America Paclitaxel Injection Sales by Type (2017-2022) & (K Units)

Table 85. Latin America Paclitaxel Injection Sales by Type (2023-2028) & (K Units)

Table 86. Latin America Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)

Table 87. Latin America Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)

Table 88. Latin America Paclitaxel Injection Sales by Application (2017-2022) & (K Units)

Table 89. Latin America Paclitaxel Injection Sales by Application (2023-2028) & (K Units)

Table 90. Latin America Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)

Table 91. Latin America Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)

Table 92. Latin America Paclitaxel Injection Sales by Country (2017-2022) & (K Units)

Table 93. Latin America Paclitaxel Injection Sales by Country (2023-2028) & (K Units)

Table 94. Latin America Paclitaxel Injection Revenue by Country (2017-2022) & (US$ Million)

Table 95. Latin America Paclitaxel Injection Revenue by Country (2023-2028) & (US$ Million)

Table 96. Middle East and Africa Paclitaxel Injection Sales by Type (2017-2022) & (K Units)

Table 97. Middle East and Africa Paclitaxel Injection Sales by Type (2023-2028) & (K Units)

Table 98. Middle East and Africa Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)

Table 99. Middle East and Africa Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)

Table 100. Middle East and Africa Paclitaxel Injection Sales by Application (2017-2022) & (K Units)

Table 101. Middle East and Africa Paclitaxel Injection Sales by Application (2023-2028) & (K Units)

Table 102. Middle East and Africa Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)

Table 103. Middle East and Africa Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)

Table 104. Middle East and Africa Paclitaxel Injection Sales by Country (2017-2022) & (K Units)

Table 105. Middle East and Africa Paclitaxel Injection Sales by Country (2023-2028) & (K Units)

Table 106. Middle East and Africa Paclitaxel Injection Revenue by Country (2017-2022) & (US$ Million)

Table 107. Middle East and Africa Paclitaxel Injection Revenue by Country (2023-2028) & (US$ Million)

Table 108. Bristol-Myers Squibb Corporation Information

Table 109. Bristol-Myers Squibb Description and Major Businesses

Table 110. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 111. Bristol-Myers Squibb Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Bristol-Myers Squibb Recent Developments

Table 113. Celgene Corporation Corporation Information

Table 114. Celgene Corporation Description and Major Businesses

Table 115. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 116. Celgene Corporation Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Celgene Corporation Recent Developments

Table 118. Hospira Corporation Information

Table 119. Hospira Description and Major Businesses

Table 120. Hospira Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 121. Hospira Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Hospira Recent Developments

Table 123. Biological E. Corporation Information

Table 124. Biological E. Description and Major Businesses

Table 125. Biological E. Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 126. Biological E. Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Biological E. Recent Developments

Table 128. Taj Accura Corporation Information

Table 129. Taj Accura Description and Major Businesses

Table 130. Taj Accura Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 131. Taj Accura Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Taj Accura Recent Developments

Table 133. Khandelwal Laboratories Corporation Information

Table 134. Khandelwal Laboratories Description and Major Businesses

Table 135. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 136. Khandelwal Laboratories Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Khandelwal Laboratories Recent Developments

Table 138. Luye Pharma Corporation Information

Table 139. Luye Pharma Description and Major Businesses

Table 140. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 141. Luye Pharma Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Luye Pharma Recent Developments

Table 143. Beijing Youcare Corporation Information

Table 144. Beijing Youcare Description and Major Businesses

Table 145. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 146. Beijing Youcare Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Beijing Youcare Recent Developments

Table 148. Beijing Union Corporation Information

Table 149. Beijing Union Description and Major Businesses

Table 150. Beijing Union Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 151. Beijing Union Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Beijing Union Recent Developments

Table 153. Haiyao Corporation Information

Table 154. Haiyao Description and Major Businesses

Table 155. Haiyao Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 156. Haiyao Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Haiyao Recent Developments

Table 158. Chuntch Corporation Information

Table 159. Chuntch Description and Major Businesses

Table 160. Chuntch Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 161. Chuntch Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Chuntch Recent Developments

Table 163. Key Raw Materials Lists

Table 164. Raw Materials Key Suppliers Lists

Table 165. Paclitaxel Injection Distributors List

Table 166. Paclitaxel Injection Customers List

Table 167. Paclitaxel Injection Market Trends

Table 168. Paclitaxel Injection Market Drivers

Table 169. Paclitaxel Injection Market Challenges

Table 170. Paclitaxel Injection Market Restraints

Table 171. Research Programs/Design for This Report

Table 172. Key Data Information from Secondary Sources

Table 173. Key Data Information from Primary Sources

List of Figures

Figure 1. Paclitaxel Injection Product Picture

Figure 3. Global Paclitaxel Injection Market Share by Type in 2021 & 2028

Figure 3. 5ml,30mg Product Picture

Figure 4. 10ml,60mg Product Picture

Figure 5. 16.7ml,100mg Product Picture

Figure 6. 25ml,150mg Product Picture

Figure 7. 50ml,300mg Product Picture

Figure 8. Global Paclitaxel Injection Market Share by Application in 2021 & 2028

Figure 9. Ovarian Cancer

Figure 10. Breast Cancer

Figure 11. Cervical Cancer

Figure 12. Pancreatic Cancer

Figure 13. Other

Figure 14. Paclitaxel Injection Report Years Considered

Figure 15. Global Paclitaxel Injection Sales 2017-2028 (K Units)

Figure 16. Global Paclitaxel Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 17. Global Paclitaxel Injection Revenue 2017-2028 (US$ Million)

Figure 18. Global Paclitaxel Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 19. Global Paclitaxel Injection Sales Market Share by Region (2017-2022)

Figure 20. Global Paclitaxel Injection Sales Market Share by Region (2023-2028)

Figure 21. North America Paclitaxel Injection Sales YoY (2017-2028) & (K Units)

Figure 22. North America Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Europe Paclitaxel Injection Sales YoY (2017-2028) & (K Units)

Figure 24. Europe Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Asia-Pacific Paclitaxel Injection Sales YoY (2017-2028) & (K Units)

Figure 26. Asia-Pacific Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)

Figure 27. Latin America Paclitaxel Injection Sales YoY (2017-2028) & (K Units)

Figure 28. Latin America Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)

Figure 29. Middle East & Africa Paclitaxel Injection Sales YoY (2017-2028) & (K Units)

Figure 30. Middle East & Africa Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)

Figure 31. The Paclitaxel Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 32. The Top 5 and 10 Largest Manufacturers of Paclitaxel Injection in the World: Market Share by Paclitaxel Injection Revenue in 2021

Figure 33. Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 34. Global Paclitaxel Injection Sales Market Share by Type (2017-2028)

Figure 35. Global Paclitaxel Injection Revenue Market Share by Type (2017-2028)

Figure 36. Global Paclitaxel Injection Sales Market Share by Application (2017-2028)

Figure 37. Global Paclitaxel Injection Revenue Market Share by Application (2017-2028)

Figure 38. North America Paclitaxel Injection Sales Market Share by Type (2017-2028)

Figure 39. North America Paclitaxel Injection Revenue Market Share by Type (2017-2028)

Figure 40. North America Paclitaxel Injection Sales Market Share by Application (2017-2028)

Figure 41. North America Paclitaxel Injection Revenue Market Share by Application (2017-2028)

Figure 42. North America Paclitaxel Injection Sales Share by Country (2017-2028)

Figure 43. North America Paclitaxel Injection Revenue Share by Country (2017-2028)

Figure 44. U.S. Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 45. Canada Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 46. Europe Paclitaxel Injection Sales Market Share by Type (2017-2028)

Figure 47. Europe Paclitaxel Injection Revenue Market Share by Type (2017-2028)

Figure 48. Europe Paclitaxel Injection Sales Market Share by Application (2017-2028)

Figure 49. Europe Paclitaxel Injection Revenue Market Share by Application (2017-2028)

Figure 50. Europe Paclitaxel Injection Sales Share by Country (2017-2028)

Figure 51. Europe Paclitaxel Injection Revenue Share by Country (2017-2028)

Figure 52. Germany Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 53. France Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 54. U.K. Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 55. Italy Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 56. Russia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 57. Asia Pacific Paclitaxel Injection Sales Market Share by Type (2017-2028)

Figure 58. Asia Pacific Paclitaxel Injection Revenue Market Share by Type (2017-2028)

Figure 59. Asia Pacific Paclitaxel Injection Sales Market Share by Application (2017-2028)

Figure 60. Asia Pacific Paclitaxel Injection Revenue Market Share by Application (2017-2028)

Figure 61. Asia Pacific Paclitaxel Injection Sales Share by Region (2017-2028)

Figure 62. Asia Pacific Paclitaxel Injection Revenue Share by Region (2017-2028)

Figure 63. China Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 64. Japan Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 65. South Korea Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 66. India Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 67. Australia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 68. China Taiwan Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 69. Indonesia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 70. Thailand Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 71. Malaysia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 72. Latin America Paclitaxel Injection Sales Market Share by Type (2017-2028)

Figure 73. Latin America Paclitaxel Injection Revenue Market Share by Type (2017-2028)

Figure 74. Latin America Paclitaxel Injection Sales Market Share by Application (2017-2028)

Figure 75. Latin America Paclitaxel Injection Revenue Market Share by Application (2017-2028)

Figure 76. Latin America Paclitaxel Injection Sales Share by Country (2017-2028)

Figure 77. Latin America Paclitaxel Injection Revenue Share by Country (2017-2028)

Figure 78. Mexico Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 79. Brazil Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 80. Argentina Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 81. Middle East and Africa Paclitaxel Injection Sales Market Share by Type (2017-2028)

Figure 82. Middle East and Africa Paclitaxel Injection Revenue Market Share by Type (2017-2028)

Figure 83. Middle East and Africa Paclitaxel Injection Sales Market Share by Application (2017-2028)

Figure 84. Middle East and Africa Paclitaxel Injection Revenue Market Share by Application (2017-2028)

Figure 85. Middle East and Africa Paclitaxel Injection Sales Share by Country (2017-2028)

Figure 86. Middle East and Africa Paclitaxel Injection Revenue Share by Country (2017-2028)

Figure 87. Turkey Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 88. Saudi Arabia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 89. UAE Paclitaxel Injection Revenue (2017-2028) & (US$ Million)

Figure 90. Paclitaxel Injection Value Chain

Figure 91. Paclitaxel Injection Production Process

Figure 92. Channels of Distribution

Figure 93. Distributors Profiles

Figure 94. Bottom-up and Top-down Approaches for This Report

Figure 95. Data Triangulation

Figure 96. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Paclitaxel Injection Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-18136

Global Paclitaxel Injection Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions